Cointime

Q Chip

company

About

Q Chip develops a range of sustained-release biogeneric and biotherapies products.

  • 11 - 50

Highlights

Total Funding Amount
£1M $6.57M
Funding Rounds
3
Investors
4

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
£1M
Industries
Biotechnology,Life Science,Therapeutics
Founded date
Jan 1, 2003
Number Of Employee
11 - 50
Operating Status
Close

Q Chip is a biopharmaceutical drug delivery company developing a range of sustained-release biogeneric and biotherapies products (Q-Spheraâ„¢).

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
£1M $6.57M
Q Chip has raised a total of £1M $6.57M in funding over 2 rounds. Their latest funding was raised on May 20, 2011 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 20, 2011 Series C $6M 2 Nedermaas Hightech Ventures
Limburg Ventures 		— Detail
Dec 7, 2009 Series Unknown £1M 1 Curzon Park Capital — Detail
Feb 15, 2006 Series Unknown $574K 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
3
4
Q Chip is funded by 4 investors. Nedermaas Hightech Ventures and Limburg Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Nedermaas Hightech Ventures Yes Series C
Limburg Ventures Yes Series C
Curzon Park Capital Yes Series Unknown
E-Synergy — Series Unknown
Cointime
Содержание
компания